Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329) Cash Flow for Dividends: HK$0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:08329 Shenzhen Neptunus Interlong Bio-Technique Co Ltd HKSE:08329
48 GF Score
Price HK$0.10
GF Value HK$0.14
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Shenzhen Neptunus Interlong Bio-Technique Co Cash Flow for Dividends?

Shenzhen Neptunus Interlong Bio-Technique Co HKSE:08329 -5.71% 48 Cash Flow for Dividends is HK$0 Mil as of Jun. 2026. GuruFocus rates HKSE:08329 with a GF Score™ of 48/100 and a GF Value™ of HK$0.14 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Shenzhen Neptunus Interlong Bio-Technique Co's cash flow for dividends for the six months ended in Jun. 2026 was HK$0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Jun. 2026 was HK$0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Shenzhen Neptunus Interlong Bio-Technique Co's quarterly payment of dividends declined from Jun. 2025 (HK$-263 Mil) to Dec. 2025 (HK$-5 Mil) and declined from Dec. 2025 (HK$-5 Mil) to Jun. 2026 (HK$0 Mil).

Shenzhen Neptunus Interlong Bio-Technique Co's annual payment of dividends stayed the same from Dec. 2023 (HK$0 Mil) to Dec. 2024 (HK$0 Mil) but then increased from Dec. 2024 (HK$0 Mil) to Dec. 2025 (HK$-266 Mil).

Shenzhen Neptunus Interlong Bio-Technique Co Cash Flow for Dividends Related Terms

Shenzhen Neptunus Interlong Bio-Technique Co Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Shenzhen Neptunus Interlong Bio-Technique Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenzhen Neptunus Interlong Bio-Technique Co Cash Flow for Dividends Chart

Shenzhen Neptunus Interlong Bio-Technique Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -265.70

Shenzhen Neptunus Interlong Bio-Technique Co Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -263.15 -5.05 0.00
HKSE:08329
48GF Score
Shenzhen Neptunus Interlong Bio-Technique Co Ltd HKSE:08329
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shenzhen Neptunus Interlong Bio-Technique Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of HK$0 Mil mean?
Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329) has a Cash Flow for Dividends of HK$0 Mil as of Jun. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Shenzhen Neptunus Interlong Bio-Technique Co and its competitors.
Is Shenzhen Neptunus Interlong Bio-Technique Co's Cash Flow for Dividends too high?
Shenzhen Neptunus Interlong Bio-Technique Co's current Cash Flow for Dividends is HK$0 Mil. Overall, Shenzhen Neptunus Interlong Bio-Technique Co has a GF Score™ of 48/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Neptunus Interlong Bio-Technique Co's Cash Flow for Dividends compare to ZTS?
Shenzhen Neptunus Interlong Bio-Technique Co's Cash Flow for Dividends of HK$0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Shenzhen Neptunus Interlong Bio-Technique Co and its competitors. Shenzhen Neptunus Interlong Bio-Technique Co's current Cash Flow for Dividends is HK$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Neptunus Interlong Bio-Technique Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$0.14, compared to a current price of HK$0.10 — trading 29.3% below its estimated fair value. The current Cash Flow for Dividends is HK$0 Mil. Shenzhen Neptunus Interlong Bio-Technique Co's overall GF Score™ is 48/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329), the current Cash Flow for Dividends is HK$0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329) Overvalued in 2026?

Based on GuruFocus' analysis, Shenzhen Neptunus Interlong Bio-Technique Co stock appears to be undervalued. The current stock price of HK$0.10 is trading 29.3% below its estimated GF Value™ of HK$0.14. GuruFocus considers Shenzhen Neptunus Interlong Bio-Technique Co to be Modestly Undervalued.

Key valuation signals for HKSE:08329:

  • Cash Flow for Dividends: HK$0 Mil
  • GF Value™: HK$0.14 vs. price of HK$0.10 (29.3% below fair value)
  • GF Score™: 48/100 with 3 warning signs

No single metric tells the full story. See the HKSE:08329 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shenzhen Neptunus Interlong Bio-Technique Co Business Description

Address 979 King’s Road, 43rd Floor, One Taikoo Place, Quarry Bay, Hong Kong, HKG
Shenzhen Neptunus Interlong Bio-Technique Co Ltd is engaged in the research and development, manufacturing, and selling of medicines and medical devices. It is also involved in the purchase and sale of medicines and healthcare food products. The group's revenue and results from operations are mainly derived from activities in the PRC. The operating segments of the company are the Manufacturing and selling of medicines and medical devices; and the Sales and distribution of medicines, healthcare products, and medical devices.. The majority of revenue is generated from the Manufacturing and selling of medicines and medical devices segment.
48GF Score

Get the complete analysis for HKSE:08329

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.10
Price
HK$0.14
GF Value